开发和优化Eva1 (MPZL2) 的目标是化学抗原受体T细胞
Masahide Osaki1, Seitaro Terakura2, Shiho Hirano1
1Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Journal for immunotherapy of cancer
|May 9, 2025
概括
化学抗原受体T (CAR-T) 细胞疗法针对表皮V样抗原1 (Eva1) 显示出对固体瘤的前景. 优化的Eva1CAR-T细胞在临床前模型中表现出显著的疗效,这表明它有可能用于治疗各种Eva1阳性固体癌症.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞工程 细胞工程
背景情况:
- 化学抗原受体T (CAR-T) 细胞疗法用于血液恶性瘤,但不是固体瘤.
- 表皮V型抗原1 (Eva1),是各种瘤细胞上的表面蛋白质,是固体瘤治疗的潜在目标.
研究的目的:
- 开发和优化针对固体瘤的表皮V样抗原1 (Eva1) 的CAR-T细胞.
- 在临床前模型中评估Eva1向的CAR-T细胞的疗效和安全性.
主要方法:
- 对Eva1进行人性化的单链可变片段序列生成.
- 创建了六个人性化的Eva1CAR-T细胞结构,并针对特异性和扩散进行了优化.
- 实验室和体内异种移植小鼠模型被用于评估治疗疗效和细胞因子释放.
主要成果:
- 在各种瘤细胞系上证实了Eva1的表达,在正常单细胞上表达较弱.
- 经过优化,具有短间距域和特定细胞内域的Eva1CAR-T细胞显示出增强的疗效.
- 一剂人性化的Eva1CAR-T细胞在肺癌和胰腺癌模型中显示出显著的治疗效果.
结论:
- 人性化的Eva1CAR-T细胞对Eva1阳性固体瘤具有有前途的治疗潜力.
- 需要进一步研究对正常组织的点/瘤外影响.
相关概念视频
Eukaryotic Evolution
29.8K
The endosymbiont theory is the most widely accepted theory of eukaryotic evolution; however, its progression is still somewhat debated. According to the nucleus-first hypothesis, the ancestral prokaryote first evolved a membrane to enclose DNA and form the nucleus. Conversely, the mitochondria-first hypothesis suggests that the nucleus was formed after endosymbiosis of mitochondria.
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
29.8K
In-vitro Mutagenesis
13.6K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.6K
The Eukaryotic Promoter Region
2.8K
2.8K
Maintenance of the ES Cell State
2.1K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.1K
Amplifying Signals via Enzymatic Cascade
8.2K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.2K
Eukaryotic Transcription Activators
10.7K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
10.7K


